Ad
ANNX Quote Trading Chart Annexon Inc.
home / stock / annx / annx quote
Quote | Annexon Inc. (NASDAQ:ANNX)
| Last: | $6.27 |
|---|---|
| Change Percent: | 9.04% |
| Open: | $5.78 |
| Close: | $5.75 |
| High: | $6.29 |
| Low: | $5.77 |
| Volume: | 400,781 |
| Last Trade Date Time: | 09/09/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
ANNX Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $6.27 | $5.78 | $5.75 | $6.29 | $5.77 | 400,781 | 09-09-2024 |
| $5.75 | $5.85 | $5.75 | $6 | $5.535 | 594,875 | 09-06-2024 |
| $5.82 | $5.59 | $5.82 | $5.9 | $5.56 | 901,869 | 09-05-2024 |
| $5.59 | $5.41 | $5.59 | $5.63 | $5.31 | 586,051 | 09-04-2024 |
| $5.41 | $5.61 | $5.41 | $5.72 | $5.38 | 1,026,741 | 09-03-2024 |
| $5.7 | $5.97 | $5.7 | $6.04 | $5.66 | 614,381 | 09-02-2024 |
| $5.7 | $5.97 | $5.7 | $6.04 | $5.66 | 614,381 | 08-30-2024 |
| $5.93 | $5.95 | $5.93 | $6.205 | $5.92 | 684,075 | 08-29-2024 |
| $5.94 | $5.99 | $5.94 | $6.12 | $5.83 | 682,207 | 08-28-2024 |
| $6.05 | $5.93 | $6.05 | $6.18 | $5.81 | 554,817 | 08-27-2024 |
| $6.11 | $5.92 | $6.11 | $6.2486 | $5.88 | 1,150,977 | 08-26-2024 |
| $5.89 | $5.81 | $5.89 | $6 | $5.71 | 1,212,073 | 08-23-2024 |
| $5.8 | $5.91 | $5.8 | $6.01 | $5.68 | 609,080 | 08-22-2024 |
| $5.91 | $5.99 | $5.91 | $6.16 | $5.9 | 1,457,076 | 08-21-2024 |
| $5.99 | $5.93 | $5.99 | $6.13 | $5.75 | 1,414,808 | 08-20-2024 |
| $5.98 | $6.12 | $5.98 | $6.3 | $5.7919 | 1,686,404 | 08-19-2024 |
| $6.1 | $5.97 | $6.1 | $6.23 | $5.96 | 766,743 | 08-16-2024 |
| $5.98 | $5.78 | $5.98 | $6.03 | $5.74 | 1,534,964 | 08-15-2024 |
| $5.61 | $5.68 | $5.61 | $5.73 | $5.37 | 662,901 | 08-14-2024 |
| $5.685 | $5.55 | $5.685 | $5.89 | $5.55 | 878,151 | 08-13-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the Fovea Region Critical for Visual Acuity ARCHER II Phase 3 Pivotal Program in GA Underway with Data Expected Second Half 2026 ...
-
BRISBANE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain, and eye, today announced the strengthening of its senior leadership team with the appointment ...
-
BRISBANE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain and eye, today announced that Douglas Love, Esq., president & chief executive officer, will part...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...